Menu

Two Senior GOP Senators Suggest 340B Linked to Generic Drug Shortages

William Newton, Associate Editor/Senior Writer 340B Report Views
Sen. Mike Crapo (R-Idaho), ranking member of the Senate Finance Committee, said penny pricing under 340B warranted “serious scrutiny in the context of generic products.”
Two Republican Senators on an influential committee suggested during a hearing on Tuesday that 340B discounts could contribute to certain [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

New Part B Drug Claims Modifier Requirement for 340B Entities Starts Jan. 1

Amid Record Drugmaker Refunds, No Adverse Audit Findings for Teva

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live

Sliding Sidebar

Link to spotlight on Sean Hall of Visante

340B Report Categories

More Categories

Recent Articles

Article Archives